Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Prestige Brands Holdings Inc (PBH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C9917)・商品コード:DATA904C9917
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:38
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Prestige Brands Holdings Inc (Prestige) focuses on the marketing, sales and distribution of over-the-counter (OTC) healthcare and household cleaning brands. The company offers its products for digestive care; lice treatment, household cleaning; hygiene; oral care; pain relief; pediatric care; skin care; eye care and women’s health, besides sleep aids and throat drops. It also offers antacids in Canada. The company commercializes its products through major retail channels, which include mass merchandisers, food, drug, dollar, club and convenience stores. It operates through subsidiaries in the US, Canada, and Australia and certain other international markets. Prestige is headquartered in Tarrytown, New York, the US.

Prestige Brands Holdings Inc (PBH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prestige Brands Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Prestige Brands Completes Acquisition Of Hydralyte From Hydration Pharma Trust 12
Prestige Brands Completes Acquisition Of 17 OTC Healthcare Brands From GlaxoSmithKline For US$660 Million 13
Equity Offering 16
Prestige Brands Holdings Announces Rights Offering Of Common Stock 16
Debt Offering 17
Prestige Brands Completes Private Placement Of Notes Due 2021 For US$400 Million 17
Prestige Brands Holdings Completes Private Placement Of Senior Notes Due 2020 For US$250 Million 18
Asset Transactions 19
Moberg Pharma Acquires DermoPlast from Prestige 19
Nutrition & Fitness Acquires Worldwide Rights to e.p.t from Prestige Brands Holdings 21
Moberg Pharma Acquires Three US OTC Brands from Prestige Brands for USD40 Million 22
WellSpring Pharma Acquires Bonine from Prestige Brands 24
Acquisition 25
Prestige Brands Acqiures Insight Pharma 25
Recordati Completes Acquisition Of Laboratorios Casen Fleet From C.B. Fleet For US$122.5 Million 27
Prestige Brands Acquires Care Pharma, OTC Healthcare Products Company 29
Prestige Brands Holdings Inc – Key Competitors 31
Prestige Brands Holdings Inc – Key Employees 32
Prestige Brands Holdings Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Financial Announcements 35
Feb 01, 2018: Prestige Brands Holdings Reports Fiscal 2018 Third Quarter Results 35
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prestige Brands Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Prestige Brands Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Prestige Brands Completes Acquisition Of Hydralyte From Hydration Pharma Trust 12
Prestige Brands Completes Acquisition Of 17 OTC Healthcare Brands From GlaxoSmithKline For US$660 Million 13
Prestige Brands Holdings Announces Rights Offering Of Common Stock 16
Prestige Brands Completes Private Placement Of Notes Due 2021 For US$400 Million 17
Prestige Brands Holdings Completes Private Placement Of Senior Notes Due 2020 For US$250 Million 18
Moberg Pharma Acquires DermoPlast from Prestige 19
Nutrition & Fitness Acquires Worldwide Rights to e.p.t from Prestige Brands Holdings 21
Moberg Pharma Acquires Three US OTC Brands from Prestige Brands for USD40 Million 22
WellSpring Pharma Acquires Bonine from Prestige Brands 24
Prestige Brands Acqiures Insight Pharma 25
Recordati Completes Acquisition Of Laboratorios Casen Fleet From C.B. Fleet For US$122.5 Million 27
Prestige Brands Acquires Care Pharma, OTC Healthcare Products Company 29
Prestige Brands Holdings Inc, Key Competitors 31
Prestige Brands Holdings Inc, Key Employees 32
Prestige Brands Holdings Inc, Subsidiaries 33

List of Figures
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prestige Brands Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10

★調査レポート[Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C9917)販売に関する免責事項を必ずご確認ください。
★調査レポート[Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆